Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
Saturable Leptin Transport Across the BBB Persists in EAE Mice.
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
Preliminary results after upper cervical chiropractic care in patients with chronic cerebro-spinal venous insufficiency and multiple sclerosis.
Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity.
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.
The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions.
The role of IL-17 in CNS diseases.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration.
The need for a multiple sclerosis registry in the Gulf Region.
The role of invariant NKT cells in organ-specific autoimmunity.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
Pages
« first
‹ previous
…
397
398
399
400
401
402
403
404
405
…
next ›
last »